Prof Anushka Patel
MBBS SM PhD FRACP FCSANZ

Chief Scientist, The George Institute for Global Health

 

Executive Director, The George Institute India

 

Professor of Medicine, University of Sydney

 

Cardiologist, Royal Prince Alfred Hospital

  • Professor Anushka Patel is a professor in the Sydney Medical School, the Chief Scientist of The George Institute for Global Health and an honorary cardiologist at Royal Prince Alfred Hospital. She completed her undergraduate medical training at the University of Queensland in 1989, and her training in cardiology (leading to Fellowship of the Royal Australian College of Physicians) in Sydney. She has a Master of Science degree in Epidemiology from Harvard University and a PhD in Medicine from the University of Sydney. Both in her research and clinical practice, Professor Patel has a particular focus on cardiovascular preventive care. She currently holds a National Health & Medical Research Council Senior Research Fellowship and supervises a number of doctoral students from Australia and overseas.

    1. Management of blood pressure and lipids
    2. General Cardiology
  • Selected recent publications (click here more complete list)

    • Peiris D, Usherwood T, Panaretto K, Harris M, Hunt J, Patel B, Zwar N, Redfern J, MacMahon S, Colagiuri S, Hayman N, Patel A. The Treatment Of cardiovascular Risk in Primary care using Electronic Decision suppOrt (TORPEDO) study-  protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary health care. BMJ Open 2012 (in press 19th October 2012
    • Morton J, Zoungas S, Li Q, Patel A, Celermajer DS, Chalmers J, Beulens JWJ, Stolk RP, Ng MKC. Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy – results of the ADVANCE study. Diabetes Care 2012; 35(11):2201-6
    • Woodward M, Patel A, Zoungas S, Liu L, Pan C Poulter P, Januszewicz A, Tandon N, Joshi P, Heller S,  Neal B, Chalmers J.  Does glycemic control offer similar benefits amongst patients with diabetes in different regions of the world? Results from the ADVANCE trial. Diabetes Care 2011; 34(12):2491-5
    • Rodgers A, Patel A, Berwanger O, Bots M, Grimm R, Grobbee DR, Jackson R, Neal B, Neaton J, Poulter N, Rafter N, Raju PK, Reddy KS, Thom S, Vander Hoorn S.  An international randomised placebo-controlled trial of a four-component combination pill (“polypill”) in people at raised risk of cardiovascular disease. PLoS ONE 2011; 6(5): e19857. doi:10.1371/journal.pone.0019857
    • Peiris D, Usherwood T, Weeramanthri T, Cass A, Patel A. New tools for an old trade: a sociotechnical appraisal of how electronic decision support is used by primary care practitioners. Sociology of Health and Illness 2011; 33(7):1002-18
    • Zoungas S, Patel A, Chalmers J, de Galan B, Li Q, Billot L, Woodward M, Ninomiya T, Neal B, MacMahon S, Grobbee DE, Kengne AP, Marre M, Heller S, for the ADVANCE Collaborative Group. Severe hypoglycemia and the risks of vascular events and death. New England Journal of Medicine 2010; 363:1410-1418.
    • Jun M, Foote C, Lv J, Neal B, Patel A, Nicholls S, Grobbee DE, Cass A, Chalmers J, Perkovic V.  Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. Lancet 2010; 375: 1875-1884.
    • Heeley E, Peiris D, Patel A, Cass A, Weekes A, Morgan C, Anderson C, Chalmers J. Cardiovascular risk perception and the evidence practice gap in Australian General Practice (the AusHEART study).  Medical Journal of Australia 2010; 192: 254-259
    • Peiris D, Joshi R, Webster R, Groenestein P, Usherwood T, Heeley E, Turnbull F, Lipman A, Patel A. An Electronic Clinical Decision Support Tool to Assist Primary Care Providers in Cardiovascular Disease Risk Management: Development and Mixed Methods Evaluation. Journal of Medical Internet Research 2009; 11(4):e51.
    • Peiris D, Patel A, Cass A, Howard M, Tchan M, Brady J, DeVries J, Rickards B, Yarnold D, Hayman N, Brown A. Cardiovascular disease risk management for Aboriginal and Torres Strait Islander peoples in primary health care settings - findings from the Kanyini Audit. Medical Journal of Australia 2009; 191:304-309.
    • Du X, Ninomiya T, de Galan B, Abadir E, Chalmers J, Pillai A, Woodward M, Cooper M, Harrap S, Hamet P, Poulter N, Lip G, Patel A.  Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation. European Heart Journal 2009; 30:1128-1135.
    • Patel A, Peiris D, Groenestein P.  How to Treat – Cardiovascular Disease Risk Assessment.  Australian Doctor 2009 (April 10th): 25-32.
    • Patel A. Cardiovascular risk – who should we treat and how much should we stratify? Heart 2009; 95:783-784.
    • Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee DE, Hamet P, Harrap S, Heller S, Liu LS, Mancia G, Mogensen CE, Pan CY, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan B, Joshi R, Travert F, ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. New England Journal of Medicine 2008; 358: 2560-2572.
    • Gao R, Patel A, Gao W, Hu D, Huang D, Kong L, Qi W, Wu Y, Yang Y, Harris P, Algert C, Groenestein P, Turnbull F, on behalf of the CPACS Investigators.  Prospective observational study of acute coronary syndromes in China: practice patterns and outcomes.  Heart 2008; 94: 554-560.
    • Patel A, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N, Marre M, Cooper M, Glasziou P, Grobbee DE, Hamet P, Heller S, Liu LS, Mancia G,  Mogensen CE, Pan CY, Rodgers A, Williams B, ADVANCE Collaborative Group.  Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.  Lancet 2007; 370:829-840.